Cuts to international aid programmes could trigger a rise in antimicrobial resistance (AMR) and cause global annual gross domestic product (GDP) losses of $1.7tn (£1.3tn; €1.5tn) within 25 years, researchers have warned.
The new study, conducted by the Center for Global Development and funded by the UK government, combined health projections from the Institute for Health Metrics and Evaluation with literature reviews and models of healthcare costs, economic resilience, macroeconomics, intervention costs, and GDP based health valuation to estimate the global economic burden of AMR.1
The paper’s confidence interval was generated using assumptions around hospital admissions and the future cost of treating AMR. The researchers predicted that the global …
